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Edited by Jesus AvilaAbstract Neuromedin U (NMU), an anorexigenic peptide, was
originally isolated from porcine spinal cord in 1985. As NMU is
abundant in the anterior pituitary gland, we investigated the ef-
fects of NMU on gonadotropin secretion. Both NMU and its
receptors, NMUR1 and NMUR2, were expressed in the pitui-
tary gland. NMU suppressed LH and FSH releases from rat
anterior pituitary cells. Moreover, NMU-deﬁcient mice exhibit
an early onset of vaginal opening. The LHb/FSHb ratio, which
is an index of puberty onset, is high in young NMU-deﬁcient
mice. These results indicate that NMU suppresses gonadotropin
secretion and regulates the onset of puberty.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Vaginal opening1. Introduction
Neuromedin U (NMU) was ﬁrst isolated from porcine
spinal cord in 1985; this peptide was named for its strong con-
tractile eﬀect on the uterus [1]. NMU is present in many tis-
sues, including the gastrointestinal tract, spinal cord,
pituitary and hypothalamus [2–5]. Two types of the NMU
receptor have been identiﬁed, NMUR1 (FM-3) and NMUR2
(FM-4). While NMUR1 is abundantly expressed in peripheral
tissues, such as the small intestines, skin, spinal cord, and pitu-
itary gland [4,5], the expression of NMUR2 is restricted to spe-
ciﬁc regions of in the hypothalamic paraventricular nucleus
[6,7]. NMU has a variety of functions; it contracts the small
intestine [1], regulates pain sensation in the spinal cord [8], in-
duces inﬂammation of the skin [9], suppresses food intake and
stimulates energy expenditure [10–12].
Recently, neuromedin S (NMS) was discovered from rat
brain as the second endogenous ligand for NMUR and shown
that the amino acid sequence of NMS is highly homologous to
that of NMU. NMS is expressed speciﬁcally in the hypotha-
lamic suprachiasmatic nuclei (SCN), the center of biological
rhythm [13]. It is reported that NMS regulates food intake
[14].*Corresponding author. Fax: +81 942 31 5212.
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doi:10.1016/j.febslet.2006.05.025Although NMU is expressed at highest levels in the pituitary
[3,15], the functions of this peptide in the pituitary gland are
unclear. One role of NMU may be to regulate sexual matura-
tion and/or gonadal functions, as pituitary gland is the center
of gonadotropic hormone secretion, producing luteinizing hor-
mone (LH) and follicle-stimulating hormone (FSH). The eﬀect
of NMU on gonadotropic hormone secretion, however, is con-
troversial. Quan et al. reported that intracerebroventricular
administration of NMU to rats suppressed pulsatile LH secre-
tion [16]. In contrast, Gartlon et al. reported that NMU did
not aﬀect plasma LH levels [17]. To clarify the eﬀect of
NMU secreted from pituitary gland on gonadotropic hormone
secretion, we analyzed the gonadal functions in NMU-deﬁ-
cient (NMU-KO) mice.2. Materials and methods
2.1. Animals
We maintained NMU-KO mice and Sprague-Dawley (SD) female
rats (10 weeks-old; CLEA Japan, Tokyo, Japan) under controlled tem-
perature and light conditions (light on 0700–1900). Animals were fed
standard rodent chow pellets with water ad libitum. The generation
of NMU-KO mice was previously described in detail [12]. The age
of vaginal opening in NMU-KO mice and wild type (WT) mice was
documented by monitoring mice every morning (0900–0930) from 25
days to 40 days of age.
2.2. Anterior pituitary primary cell cultures
The anterior pituitaries of 20 female SD rats were separated from the
neurointermediate lobes. Cells were dissociated at 37 C for 2 h in
DMEM-disperation medium containing DMEM (Invitrogen Corp.,
Carlsbad, CA, USA), 20 mM HEPES, and 0.1% BSA with 0.25% tryp-
sin (NACALAI TESQUE, Kyoto, Japan). After centrifugation at
400 · g for 10 min, pellets were resuspended in DMEM buﬀer contain-
ing 100 U/ml penicillin G potassium, 1 mg/ml streptomycin sulfate,
and 10% FCS. After plating in 24-well culture plates at a density of
4 · 105 cells/well, cultures were maintained at 37 C in a humidiﬁed
atmosphere of 5% CO2–95% O2 for 48 h. After the preincubation per-
iod, the medium was removed. Following several washes with saline,
cell cultures were treated for 1 h with either medium or 105 or
106 M NMU (Peptide Institute, Osaka, Japan) in incubator at
37 C. The medium was then centrifuged at 21600 · g for 5 min at
4 C and LH and FSH were measured.
2.3. Assays of LH and FSH
To quantify the levels of LH and FSH in culture media, we used
commercially available ELISA kit speciﬁc for LH (Amersham Biosci-
ences, Tokyo, Japan) and RIA kit for FSH (SCETI Co., LTD, Tokyo,
Japan) according to the manufacturer’s instructions. This procedure’s
sensitivity to measure LH and FSH was 0.1 ng/ml and 0.09 ng/tube.
Intra-assay variation for LH and FSH was 7.6% and 4.2%.blished by Elsevier B.V. All rights reserved.
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Total RNA was extracted from mouse hypothalamic and pituitary
glands using TRIzol reagent (Invitrogen) according to the manufac-
turer’s instructions. First strand cDNA, synthesized using a Super-
script preampliﬁcation system (Invitrogen) and was used in
subsequent PCR and real-time PCR ampliﬁcation.
2.5. PCR analysis of NMU, NMUR1, and NMUR2 expression
Primers are shown in Table 1A. PCR was performed in a ﬁnal vol-
ume of 50 ll containing a 1 ll-aliquot of ﬁrst strand cDNA, 0.2 mM
deoxy-NTPs, 2 lM sense and antisense primers, and 1.25 U Ex Taq
polymerase in the provided buﬀer (TaKaRa, Tokyo, Japan). The
PCR conditions employed an initial denaturation for 1 min at 98 C,
which was followed by 35 cycles of denaturation for 20 sec at 98 C,
annealing for 30 sec at 60 C, extension for 30 sec at 72 C, and a ﬁnal
5 min extension at 72 C. The PCR products were electrophoresed on a
2% agarose gels in the presence of ethidium bromide.
2.6. Real-time PCR analysis of GnRH, LH, and FSH
Real-time quantitative PCR was performed on an ABI PRISM
7000 Sequence Detection System (PE Applied Biosystems, Foster
City, CA) using a SYBR Green PCR Kit (QIAGEN, Tokyo, Ja-
pan). Primers are described in Table 1B. Each sample was analyzed
in duplicate in addition to standards and no-template controls. Reac-
tions contained 500 ng cDNA, 0.15 lM primers, and 25 ll 2· Quan-
tiTect SYBR Green PCR Master Mix (QIAGEN, Tokyo, Japan) in a
ﬁnal volume of 50 ll. After an initial 15 min at 95 C to activate the
HotStarTaq DNA polymerase, PCR fragments were ampliﬁed by 40
cycles of denaturation for 30 sec at 94 C, annealing for 30 sec at
60 C, and extension for 60 sec at 72 C. The relative mRNA levels
were standardized to a housekeeping gene, glyceraldehydes-3-phos-
phate dehydrogenase.Table 1
Primer sequences used for PCR and real-time PCR analyses
cDNA Sequence (50–3 0) Product size (bp)
(A) PCR primer
NMU
S AGGGTGTGCCAATATCACCTCAAAGAT 402
AS CTTGTTGACCTCTTCCCGTTGCGTGGC
NMUR1
S ATATGCTGGTGCTCCTGGTGGGCTT 323
AS CCGGCCCCCGGCAGGGCACAGTT
NMUR2
S AGACACCCACCAACTACTAT 302
AS AGACCACAGAGAAGCTCCAGAC
GAPDH
S CACCATCTTCCAGGAGCGAGA 431
AS ACAGCCTTGGCAGCACCAGT
(B) Real-time PCR primer
GnRH
S AGATGGGCAAGGAGGTGGAT 103
AS TTCCAGAGCTCCTCGCAGAT
LHb
S TGATGAAGCTGGCTGAGGAA 129
AS CGCAAGCTCCCGGTAGGT
FSHb
S TGATGAAGCTGGCTGAGGAA 136
AS TTGGTTACTACCTCCTGTCCTGTCT
GAPDH
S AGGACACTGAGCAAGAGAGG 94
AS CTGTTATTATGGGGGTCTGG
S, sense primer; AS, antisense primer; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase.2.7. Statistical analysis
Results are presented as means ± S.E.M. for each group. Analysis of
Kruskal–Wallis test was used to evaluate experiments of the LH and
FSH releasing. Experiment data of NMU-KO mice was determined
by two-way ANOVA followed by Mann–Whitney U test. The criterion
for statistical signiﬁcance was P < 0.05 for all tests. We used the statis-
tical software program StatView-J 5.0 (SAS Institute, NC, USA) for all
analyses.3. Results
3.1. Messenger RNA expressions of NMU and NMU receptor in
hypothalamus and pituitary of NMU-KO mice
First, we conﬁrmed NMU mRNA in hypothalamus and
pituitary gland of WT mice (Fig. 1). In contrast, NMU mRNA
could not be detected in NMU-KO mice.
NMUR1 and NMUR2 mRNA expressions were observed in
hypothalami and pituitary glands of both WT and NUM-KO
mice (Fig. 1). Thus, NMU and its receptors are expressed in
the mouse hypothalamus and pituitary gland.
3.2. Induction by NMU of LH and FSH release from rat
anterior pituitary primary cell cultures
NMU suppressed LH release from rat anterior pituitary cells
in a dose-dependent manner (control: 1.52 ± 0.11 ng/ml, NMU
105 M: 1.14 ± 0.08 ng/ml) (Fig. 2A). FSH release from rat
anterior pituitary cells tended to be suppressed by treatment
with NMU (control: 1.84 ± 0.04 ng/ml, NMU 105 M:
1.72 ± 0.03 ng/ml) (Fig. 2B).NMU
NMUR1
NMUR2
GAPDH
Hypothalamus Pituitary
WT KO WT KO NTC
402 bp
323 bp
302 bp
431 bp
Fig. 1. Expression of NMU, NMUR1 and NMUR2 mRNAs in the
hypothalamus and pituitary gland, as determined by PCR. WT, wild
type mice; KO, NMU-KO mice; NTC, no template control.
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Fig. 2. Suppression of LH (A) and FSH (B) releases from rat anterior
pituitary cells by NMU. Control (n = 6), NMU 106 M (n = 6), NMU
105 M (n = 6). *P < 0.05 vs. control.
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We found that vaginal opening in NMU-KO mice occurred
earlier than in WT mice; vaginal opening in 50% of the mice
occurred at 34.5 days of age in NMU-KO mice and 38.8 days
of age in WT mice (Fig. 3A). The average day of vaginal
opening in NMU-KO mice was 35.1 ± 0.5 days, in compari-
son to 37.7 ± 0.8 days in WT mice (Fig. 3B). Thus, vaginal
opening of NMU-KO mice occurred earlier than that of
WT mice.
3.4. Messenger RNA level of GnRH, LHb, and FSHb in female
NMU-KO mice
In the hypothalamus, GnRH mRNA was similar in WT and
NMU-KO mice. In both WT and NMU-KO mice, however,
the levels of GnRH mRNA were higher in 35-day-old than
in 30-day-old (Fig. 4A).
Next, we investigated the mRNA levels of LHb and FSHb in
the pituitary gland. In comparison to WT mice, the levels ofA B
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Fig. 3. The timing of vaginal opening in WT and NMU-KO mice. (A)
Percentage curves of vaginal opening in the rodent population
examined. The Y-axis indicates percentage of mice exhibiting vaginal
opening. (B) The average age at vaginal opening. WT, wild type mice;
KO, NMU-KO mice. *P < 0.05.
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Fig. 4. Levels of GnRH (A), LHb (B) and FSHb (C) mRNAs determined by
(D) The ratio of LHb/FSHb mRNA levels in wild type and NMU-KO mic
(n = 11), KO (n = 13). *P < 0.05 vs. WT, P < 0.05 vs. 30 days-old.FSHb mRNA in 30-day-old NMU-KO mice were signiﬁcantly
higher than those seen in 35-day-old NMU-KO mice (Fig. 4B).
In contrast, LHb mRNA levels in 35-day-old NMU-KO mice
were signiﬁcantly higher than those seen in 30-day-old NMU-
KO mice. The levels of LHb mRNA did not signiﬁcantly diﬀer
between WT and NMU-KO mice at either age (Fig. 4C).
The LH/FSH ratio is an important index for the character-
ization of puberty onset. The ratio of LHb/FSHb in NMU-
KO mice at 35 days of age was 13.8 times higher than that seen
at 30 days (Fig. 4D).4. Discussion
Despite identiﬁcation more than 20 years ago, the functions
of NMU have remained elusive. We generated NMU-KOmice,
revealing that these mice exhibit impairments in pain sensation
[8], inﬂammation of the skin [9], and obesity [12]. In this study,
we demonstrated that NMU suppressed gonadotropin secre-
tion from the pituitary gland, a major source of NMU, which
suggests a physiological role in sexual maturation.
The pituitary gland contains signiﬁcant amounts of NMU
and expresses NMU receptors [3,15]. The physiological signif-
icance of NMU in pituitary gland, however, is unclear. We
conﬁrmed direct suppressive eﬀect of NMU on LH and FSH
release by in vitro studies using rat primary pituitary cell cul-
tures. However, Quan et al. recently reported that i.c.v. admin-
istration of NMU in ovariectomized rats suppressed pulsatile
LH secretion by inhibiting the pulsatile GnRH release in the
hypothalamus [16]. These results, thus, suggest that NMU sup-
press as LH and FSH releases from pituitary through direct
and indirect pathway.
We next investigated the timing of puberty onset using
NMU-KO mice by evaluating the age of vaginal opening. Vag-
inal opening occurred earlier in NMU-KO mice than in WT
mice (Fig. 3). Our investigation of the changes in GnRH,
LHb, and FSHb levels in NMU-KO mice revealed that theDays
10.0
2.5
7.5
5.0
0 WT KO WT KO
30 35
*
†
(× 
10
   c
op
ies
)
-
1 
FS
H-
be
ta
/G
AP
DH
 m
RN
A 
LH
-b
et
a/
FS
H-
be
ta
 ra
tio
30 days-old
35 days-old
10
20
0
30
WT KO
†
real-time PCR analyses in wild type (WT) and NMU-KO (KO) mice.
e. 30-days-old mice; WT (n = 8), KO (n = 13), 35-days-old mice; WT
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NMU-KO mice than those in WT mice. In contrast, GnRH
mRNA expression did not diﬀer between NMU-KO and WT
mice (Fig. 4). This result suggests that the precocious puberty
observed in NMU-KO mice is due to the change of LH and
FSH synthesis but not GnRH synthesis.
In rats, LHb mRNA levels rise slowly throughout the infan-
tile period. FSHb mRNA levels peak in the infantile period,
then rapidly decline [18]. The LH/FSH ratio is thus an impor-
tant index for puberty onset; LH/FSH is low in the prepubertal
period and high during puberty [19,20]. These changes in LHb
and FSHb mRNA levels occurred earlier in NMU-KO mice
than in WT mice. We demonstrated that a high LHb/FSHb ra-
tio was observed in NMU-KO mice at 35 days of age, which
was signiﬁcantly earlier than that seen in WT mice (Fig. 4D).
The rise of the LHb/FSHb ratio in the precocious period in
NMU-KO mice may cause the early sexual maturation ob-
served in these mice.
NMS speciﬁcally localizes in the SCN and does not exist in
other hypothalamic regions [13]. Reported functions of NMS
are regulation of circadian rhythm [13] and suppression of
food intake [14]. Moreover, we found that NMU-KO mice
maintained normal levels of NMS (data not shown). There-
fore, it is unlikely that NMS is also involved in the regulation
of LH and FSH releases from pituitary.
In summary, we demonstrated that NMU suppresses LH
and FSH releases from the pituitary gland. As a result,
NMU slows the onset of puberty. Thus, the secretion of
NMU from the pituitary gland is an important event in the
normal sexual maturation of rodents.
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